A medicine that is listed in the PBS to treat chronic conditions but to which only public and private hospitals with appropriate specialist facilities are allowed access because of its clinical use or other specialised features. Funding is provided under the HSD Program within s. 100 of the National Health Act 1953. CoA
Recently Added
- Giving input about what is funded on the Medicare Benefits Schedule
- Christmas Gift Guide 2022
- National Medicines Policy Review
- Patient Based Evidence: Using patient preference research for PBAC/MSAC Webinar Series 1 of 3
- Patient Based Evidence: Using Patient Reported Outcomes Measures (PROMs): Webinar Series 2 of 3